Low Vitamin D Status Predicts Poor Clinical Outcome in Advanced Melanoma Treated With Immune Checkpoint or BRAF/MEK Inhibitors: A Prospective Non-Interventional Side-by-Side Analysis

Low Vitamin D Status Predicts Poor Clinical Outcome in Advanced Melanoma Treated With Immune Checkpoint or BRAF/MEK Inhibitors: A Prospective Non-Interventional Side-by-Side Analysis

In melanoma and other malignancies, low vitamin D status is associated with increased risk and poor prognosis. However, there are limited data of the impact of 25(OH)D serum concentration (s.c.) on clinical outcome in advanced melanoma. We tested the hypothesis that vitamin D status is predictive of...

Full description

Bibliographic Details
Main Authors: Jörg Reichrath, Florian Biersack, Stefan Wagenpfeil, Jakob Schöpe, Claudia Pföhler, Roman Saternus, Thomas Vogt
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
vitamin D
vitamin D status
low vitamin D status
advanced melanoma
melanoma
immune checkpoint inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.839816/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.839816/full

Similar Items